Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Gelatinase inhibitors prepared by Ono

March 11, 1997

MMP inhibitors from Ono

March 10, 1997

U.S. patent covers Immunex's TNFR

March 7, 1997

IVAX receives approval for generic NSAID

March 6, 1997

Selective stromelysin-1 inhibitor described by Merck & Co.

March 5, 1997

Protein kinase inhibitors reported by Roche

March 5, 1997

Teva's Tolmetin approved

March 4, 1997

Celgene receives patent for selective cytokine-inhibitory drugs

March 4, 1997

Faulding receives approval for etodolac tablets

March 4, 1997

Zeneca reports cell adhesion inhibitors

March 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...